Composition of Indigo naturalis

Abstract

A proposal for a European Pharmacopoeia monograph concerning Indigo naturalis has recently been published, whereby the indigo (1) and indirubin (2) content should be determined by HPLC‐UV. This method was tested, but problems were seen with the dosage of indigo due to poor solubility. A quantitative assay for indigo based on ¹H‐NMR was developed as an alternative. The HPLC and qNMR assays were compared with eight Indigo naturalis samples. The HPLC assay consistently gave much lower indigo concentrations because solubility was the limiting factor in sample preparation. In one sample, sucrose was identified by ¹H‐NMR as an organic additive. Simple wet chemistry assays for undeclared additives such as sugars and starch were tested with artificially spiked Indigo naturalis samples to establish their limits of detection, and sulfate ash determinations were carried out in view of a better assessment of Indigo naturalis in a future European monograph.

Key words

Indigo naturalis - indigo - indirubin - qNMR - HPLC - Pharmacopoeia monograph

References

• 1 Stöger E, Friedel F. Aktualisierung, Monographie „Indigo naturalis“. Arzneibuch der chinesischen Medizin. Stuttgart; Deutscher Apotheker Verlag 2006: 11
• 2 Chen D H, Xie J X. Chemical constituents of traditional Chinese medicine Qing Dai.  Chinese Tradit Herbal Drugs. 1984;  1 6-8
• 3 Leclerc S, Garnier M, Hoessel R, Marko D, Bibb J A, Snyder G L, Greengard P, Biernat J, Wu Y Z, Mandelkow E M, Eisenbrand G, Meijer L. Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease.  J Biol Chem. 2001;  276 251-260
• 4 Hoessel R, Leclerc S, Endicott J A, Nobel M E, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D, Niederberger E, Tang W, Eisenbrand G, Meijer L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.  Nat Cell Biol. 1999;  1 60-67
• 5 [no authors] .Monograph of the Chinese Pharmacopoeia, Engl. edition. Beijing; The Pharmacopoeia Commission of PRC 2005
• 6 [no authors] . Monograph proposal „natural indigo“.  Pharmeuropa. 2008;  20 (1) 118
• 7 Hamburger M. Isatis tinctoria – from the rediscovery of an ancient medicinal plant towards a novel anti-inflammatory phytopharmaceutical.  Phytochem Rev. 2002;  1 333-344
• 8 Oberthür C, Schneider B, Graf H, Hamburger M. The elusive indigo precursors in woad (Isatis tinctoria L.) – identification of the major indigo precursor, isatan A, and a structure revision of isatan B.  Chem Biodivers. 2004;  1 174-182
• 9 Oberthür C, Graf H, Hamburger M. The content of indigo precursors in Isatis tinctoria leaves – a comparative study of selected accessions and post-harvest treatments.  Phytochemistry. 2004;  65 3261-3268
• 10 Mohn T, Hamburger M. Glucosinolate pattern in Isatis tinctoria and I. indigotica seeds.  Planta Med. 2008;  74 885-888
• 11 Yee S K, Chu S S, Xu Y M, Choo P L. Regulatory control of Chinese proprietary medicines in Singapore.  Health Policy. 2005;  71 133-149
• 12 Benthin B, Danz H, Hamburger M. Pressurized liquid extraction of medicinal plants.  J Chromatogr A. 1999;  837 211-219
• 13 Basalo C, Mohn T, Hamburger M. Are extraction methods in quantitative assays of pharmacopoeia monographs exhaustive? A comparison with pressurized liquid extraction.  Planta Med. 2006;  72 1157-1162
• 14 Pauli G F, Jaki B U, Lankin D C. A routine experimental protocol for qHNMR illustrated with taxol.  J Nat Prod. 2007;  70 589-595
• 15 Mohn T, Potterat O, Hamburger M. Quantification of active principles and pigments in leaf extracts of Isatis tinctoria by HPLC/UV/MS.  Planta Med. 2007;  73 151-156
• 16 [no authors]. European Pharmacopeia, 6th edition. Strasbourg; Directorate for the quality of medicines of the Council of Europe 2008
• 17 Yang T, Wang Y, Xu F, Sun Q, Hu Y. Fermentation with microorganism for indigo.  Chin Tradit Patent Med. 2005;  27 914-915
• 18 Wei Q, Yang M, Xu R, Sun Q, Hu Y. New conception about the processing of Indigo naturalis.  Chin Tradit Patent Med. 2004;  26 116-118
• 19 Friedländer P, Roschdestwenski N. Über ein Oxidationsprodukt des Indigoblaus.  Ber Dtsch Chem Ges. 1915;  48 1841-1847